Pacira BioSciences Announces FDA Acceptance of sNDA for EXPAREL Use in Pediatric Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. ROIV
3. ANET
4. NKE
5. PANW
6. CL
7. SNDK
8. TAP
9. DELL
10. EAT

Go back to Pacira BioSciences Announces FDA Acceptance of sNDA for EXPAREL Use in Pediatric Patients
PACIRA (NASDAQ: PCRX) Delayed: 26.35 -0.25 (0.94%)
Previous Close $26.60    52 Week High $80.25 
Open $26.38    52 Week Low $30.25 
Day High $26.65    P/E N/A 
Day Low $26.31    EPS $-2.08 
Volume 481,690       

PACIRA (NASDAQ: PCRX) Delayed: 26.35 -0.25 (0.94%)
Previous Close $26.60    52 Week High $80.25 
Open $26.38    52 Week Low $30.25 
Day High $26.65    P/E N/A 
Day Low $26.31    EPS $-2.08 
Volume 481,690